113 related articles for article (PubMed ID: 16683783)
1. A short enantioselective pathway for the synthesis of the anti-influenza neuramidase inhibitor oseltamivir from 1,3-butadiene and acrylic acid.
Yeung YY; Hong S; Corey EJ
J Am Chem Soc; 2006 May; 128(19):6310-1. PubMed ID: 16683783
[TBL] [Abstract][Full Text] [Related]
2. High-yielding synthesis of the anti-influenza neuramidase inhibitor (-)-oseltamivir by three "one-pot" operations.
Ishikawa H; Suzuki T; Hayashi Y
Angew Chem Int Ed Engl; 2009; 48(7):1304-7. PubMed ID: 19123206
[TBL] [Abstract][Full Text] [Related]
3. A practical and azide-free synthetic approach to oseltamivir from diethyl D-tartrate.
Weng J; Li YB; Wang RB; Li FQ; Liu C; Chan AS; Lu G
J Org Chem; 2010 May; 75(9):3125-8. PubMed ID: 20394411
[TBL] [Abstract][Full Text] [Related]
4. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
Magano J
Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
[No Abstract] [Full Text] [Related]
5. An iron carbonyl approach to the influenza neuraminidase inhibitor oseltamivir.
Bromfield KM; Gradén H; Hagberg DP; Olsson T; Kann N
Chem Commun (Camb); 2007 Aug; (30):3183-5. PubMed ID: 17653382
[TBL] [Abstract][Full Text] [Related]
6. New, efficient synthesis of oseltamivir phosphate (Tamiflu) via enzymatic desymmetrization of a meso-1,3-cyclohexanedicarboxylic acid diester.
Zutter U; Iding H; Spurr P; Wirz B
J Org Chem; 2008 Jul; 73(13):4895-902. PubMed ID: 18517254
[TBL] [Abstract][Full Text] [Related]
7. High-yielding synthesis of the anti-influenza neuraminidase inhibitor (-)-oseltamivir by two "one-pot" sequences.
Ishikawa H; Suzuki T; Orita H; Uchimaru T; Hayashi Y
Chemistry; 2010 Nov; 16(42):12616-26. PubMed ID: 20859964
[TBL] [Abstract][Full Text] [Related]
8. A short and practical synthesis of oseltamivir phosphate (Tamiflu) from (-)-shikimic acid.
Nie LD; Shi XX; Ko KH; Lu WD
J Org Chem; 2009 May; 74(10):3970-3. PubMed ID: 19366236
[TBL] [Abstract][Full Text] [Related]
9. Different synthetic strategies of oseltamivir phosphate: a potent influenza neuraminidase inhibitor.
Gong J; Xu W
Curr Med Chem; 2008; 15(30):3145-59. PubMed ID: 19075659
[TBL] [Abstract][Full Text] [Related]
10. A concise and flexible synthesis of the potent anti-influenza agents tamiflu and tamiphosphor.
Shie JJ; Fang JM; Wong CH
Angew Chem Int Ed Engl; 2008; 47(31):5788-91. PubMed ID: 18613158
[No Abstract] [Full Text] [Related]
11. A practical synthesis of (-)-oseltamivir.
Satoh N; Akiba T; Yokoshima S; Fukuyama T
Angew Chem Int Ed Engl; 2007; 46(30):5734-6. PubMed ID: 17594704
[No Abstract] [Full Text] [Related]
12. [Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza].
Ruf BR; Sandow P; Lehmann P; Del Piero L; Skopnik H
Dtsch Med Wochenschr; 2008 Jun; 133(23):1259-64. PubMed ID: 18509804
[No Abstract] [Full Text] [Related]
13. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
14. Efficient formal synthesis of oseltamivir phosphate (Tamiflu) with inexpensive D-ribose as the starting material.
Osato H; Jones IL; Chen A; Chai CL
Org Lett; 2010 Jan; 12(1):60-3. PubMed ID: 19938847
[TBL] [Abstract][Full Text] [Related]
15. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
[No Abstract] [Full Text] [Related]
17. [Neuraminidase inhibitors in prophylaxis and treatment of influenza].
Nitsch-Osuch A; Brydak LB; Wardyn AK
Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619
[TBL] [Abstract][Full Text] [Related]
18. The war against influenza: discovery and development of sialidase inhibitors.
von Itzstein M
Nat Rev Drug Discov; 2007 Dec; 6(12):967-74. PubMed ID: 18049471
[TBL] [Abstract][Full Text] [Related]
19. Development of a concise synthesis of (-)-oseltamivir (Tamiflu).
Trost BM; Zhang T
Chemistry; 2011 Mar; 17(13):3630-43. PubMed ID: 21365707
[TBL] [Abstract][Full Text] [Related]
20. Tamiflu: the supply problem.
Farina V; Brown JD
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7330-4. PubMed ID: 17051628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
